Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

PARP-1 modifies the effectiveness of p53-mediated DNA damage response

Abstract

The tumour supressor protein p53 plays a key role in the cell's decision to arrest the cell cycle or undergo apoptosis following a genotoxic insult. p53 is stabilized and activated after DNA damage, however the cascade of events signalling from DNA lesions to p53 stabilization and activation is still controversial. Poly (ADP-ribosylation) of different nuclear acceptors by PARP-1 is an early event when a single strand DNA lesion is produced. We present here evidences that interplay between PARP-1 and p53 is dependent on the type of damage induced to DNA. Primary mouse embryonic fibroblasts derived from parp-1−/− mice exhibited decreased p53 accumulation and activation following γ-irradiation compared to parp-1 proficient cells. On the other hand, treatment with the single alkylating agent 2′-methyl-2′-nitrose-urea (MNU), resulted in the rapid and sustained accumulation and activation of p53 in parp-1-deficient cells, while very little accumulation was observed in parp-1+/+ cells. After IR, the turnover of the p53 inhibitory protein MDM-2 is perturbed and the level of phosphorylation of p53 at serine-15 is blunted in parp-1−/− cells. PARP-1 is determinant in the cytotoxic response to alkylating agents but only partially contributes to radiation-induced cell killing, as determined by colony forming assay. Altogether, these results suggest that PARP-1 participates in the p53 response following irradiation, resides upstream of p53 and indirectly modulates the level of phosphorylation of key substrates in this pathway while treatment with MNU results in an enhanced p53-mediated response in parp-1-null cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Agarwal ML, Agarwal A, Taylor WR, Wang ZQ, Wagner EF, Stark GR . 1997 Oncogene 15: 1035–1341

    Article  CAS  Google Scholar 

  • Banin S, Moyal L, Shieh S-H, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y . 1998 Science 281: 1674–1677

    Article  CAS  Google Scholar 

  • Beneke R, Geisen C, Zevnik B, Bauch T, Muller WU, Kupper JH, Moroy T . 2000 Mol. Cell. Biol. 20: 6695–6703

  • Burkart V, Wang ZQ, Radons JR, Heller B, Herceg Z, Stingl L, Wagner EF, Kolb H . 1999 Nat. Med. 5: 314–319

  • Canman CE, Lim DS, Cimprich KA, Taya Y, Tamay K, Sakaguchi K, Appella E, Kastan MB, Siciliano JD . 1998 Science 281: 1677–1679

  • Capoulade C, Bressac-de Paillerets B, Lefrere I, Ronsin M, Feunteun J, Tursz T, Wiels J . 1998 Oncogene 16: 1603–1610

    Article  CAS  Google Scholar 

  • Curtis SB . 1986 Radiat. Res. 106: 252–270

  • D'Amours D, Desnoyers S, D'Silva I, Poirier GG . 1999 Biochem. J. 342: 249–268

    Article  CAS  Google Scholar 

  • Dantzer F, Niedergang SVC, Trucco C, Flatter E, de la Rubia G, Oliver FJ, Rolli V, Ménissier-de-Murcia J, de Murcia G . 1999 Biochimie 81: 69–75

    Article  CAS  Google Scholar 

  • de Murcia G, Ménissier-de-Murcia J . 1994 Trends Biochem. Sci. 19: 172–176

  • Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, Dawson VL . 1997 Nat. Med. 3: 1089–1095

  • Fernet M, Ponette V, Deniaud-Alexandre E, Menissier-de-Murcia J, de Murcia G, Giocanti N, Megnin-Chanet F, Favaudon V . 2000 Int. J. Radiat. Biol. 76: 1621–1629

  • Freedman DA, Levine AJ . 1999 Cancer Res. 59: 1–7

  • Jimenez GS, Bryntessib F, Torres-Arzayus MI, Priestley A, Beeche M, Saito S, Sakaguchi K, Appella E, Jeggo PA, Taccioli GE, Wahl GM, Hubank M . 1999 Nature 6739: 81–83

  • Hall EJ . 1994 Radiobiologist for the radiologist Papadopoulos D, Cox K, Ryan JD. (eds) JB Lippincott Company: Pennsylvania pp 29–44

    Google Scholar 

  • Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, Taya Y, Gabrielli B, Chan D, Lees-Miller SP, Lavin MF . 1998 Nat. Genet. 4: 398–400

  • Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, Shkedy D . 1999 Proc. Natl. Acad. Sci. USA 96: 14973–14977

  • Lakin DL, Jackson SP . 1999 Oncogene 18: 7644–7655

    Article  CAS  Google Scholar 

  • Levine AJ . 1997 Cell 88: 323–331

    Article  CAS  Google Scholar 

  • Lu X, Lane DP . 1993 Cell. 75: 765–778

    Article  CAS  Google Scholar 

  • Malanga M, Pleschke JM, Kleczkowska HE, Althaus FR . 1998 J. Biol. Chem. 273: 11839–11843

    Article  CAS  Google Scholar 

  • Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de-Murcia J, de Murcia G . 1998 Mol. Cell. Biol. 18: 3563–3571

    Article  CAS  Google Scholar 

  • Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Nozaki T, Jishage K, Watanabe T, Sugimoto T, Nakagama H, Ochiya T, Sugimura T . 1999 Proc. Natl. Acad. Sci. USA 96: 2301–2304

  • Ménissier-de-Murcia J, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, Dierich A, LeMeur M, Walztinger C, Chambon P, de Murcia G . 1997 Proc. Natl. Acad. Sci. USA 94: 7303–7307

  • Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, Buschmann T, Ronai Z, Shiloh Y, Kastan MB, Katzir E, Oren M . 2001 Genes Dev. 15: 1067–1077

  • Oliver FJ, de Murcia G, Ménissier-de-Murcia J . 1999a Am. J. Human Genetics 64: 1282–1288

  • Oliver FJ, Ménissier-de-Murcia J, Nacci C, Decker P, Andriantsitohaina R, Müller S, de la Rubia G, Stoclet JC, de Murcia G . 1999b EMBO J 18: 4446–4454

  • Olson DC, Marechal V, Momand J, Chen J, Romocki C, Levine AJ . 1993 Oncogene 8: 2353–2360

  • Ruiz de Almodóvar JM, Núñez MI, McMillan TJ, Olea N, Mort C, Villalobos M, Pedraza V, Steel GG . 1994 Br. J. Cancer 69: 457–462

  • Schlicker A, Peschke P, Bürkle A, Hahn EW, Kim JH . 1999 Int. J. Radiat. Biol. 75: 91–100

  • Steel GG . 1997 Basic Clinical Radiobiology Steel GG. (ed) Arnold, London pp 52–57

    Google Scholar 

  • Szabo C, Dawson VL . 1998 Trends. Pharmacol. Sci. 19: 287–298

  • Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh S-Y, Taya Y, Prives C, Abraham RT . 1999 Genes Dev. 13: 152–157

  • Trucco C, Oliver FJ, de Murcia G, Ménissier-de-Murcia J . 1998 Nucleic Acids Res. 26: 2644–2649

  • Wang X, Onishi K, Takahashi A, Onishi T . 1998 Oncogene 17: 289–2825

    Article  CAS  Google Scholar 

  • Westphal C, Rowan S, Schmaltz C, Elson A, Fisher DE, Leder P . 1997 Nature Genetics 16: 397–401

    Article  CAS  Google Scholar 

  • Zhang Y, Xiong Y . 2001 Science 292: 1910–1915

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a Grant from the Fondo de Investigación Sanitarias through the project FIS 00/0948 to FJ Oliver and by the Comisión Interministerial de Ciencia y Tecnología through the project PM97-0185 to JM Ruiz de Almodóvar. MT Valenzuela (009371) and R Guerrero are supported by fellowships from Fondo de Investigación Sanitaria (BEFI) and Instituto de Salud Carlos III, respectively. We are also indebted to Dr Josiane Ménissier- de-Murcia and Dr Abelardo López-Rivas for helpful discussion and reviewing of the manuscript and to Carmen Conde and Guadalupe de la Rubia for their excellent help in getting primary cells.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F Javier Oliver.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valenzuela, M., Guerrero, R., Núñez, M. et al. PARP-1 modifies the effectiveness of p53-mediated DNA damage response. Oncogene 21, 1108–1116 (2002). https://doi.org/10.1038/sj.onc.1205169

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205169

Keywords

This article is cited by

Search

Quick links